Tonix Pharmaceuticals
TNXP
#8977
Rank
โ‚ฌ0.16 B
Marketcap
10,13ย โ‚ฌ
Share price
5.28%
Change (1 day)
-73.64%
Change (1 year)

Revenue for Tonix Pharmaceuticals (TNXP)

Revenue in 2026 (TTM): โ‚ฌ15.02 Million

According to Tonix Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ15.37 Million. In 2025 the company made a revenue of โ‚ฌ11.15 Million an increase over the revenue in the year 2024 that were of โ‚ฌ9.7 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Tonix Pharmaceuticals from 2009 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ15.02 M34.7%
2025 โ‚ฌ11.15 M15.03%
2024 โ‚ฌ9.7 M38.04%
2023 โ‚ฌ7.02 M
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2011 N/A
2010 N/A
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Aerie Pharmaceuticals
AERI
โ‚ฌ0.18 B 1,118.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
โ‚ฌ0.22 B 1,367.03%๐Ÿ‡บ๐Ÿ‡ธ USA